home / stock / nnvc / nnvc short
Short Information | NanoViricides Inc. (NYSE:NNVC)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 172,958 |
Total Actual Volume | 8,935,333 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 8,648 |
Average Short Percentage | 1.83% |
Is there a NNVC Short Squeeze or Breakout about to happen?
See the NNVC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $1.84 | $1.78 | $1.88 | $1.74 | 208,535 | 652 | 0.31% |
07-01-2024 | $1.75 | $1.85 | $1.85 | $1.7 | 347,911 | 1,521 | 0.44% |
06-28-2024 | $1.75 | $1.72 | $1.78 | $1.65 | 316,365 | 733 | 0.23% |
06-27-2024 | $1.8 | $1.73 | $1.831 | $1.73 | 218,809 | 4,636 | 2.12% |
06-26-2024 | $1.83 | $1.82 | $1.95 | $1.78 | 521,193 | 20,566 | 3.95% |
06-25-2024 | $1.94 | $1.91 | $2.04 | $1.767 | 488,498 | 20,064 | 4.11% |
06-24-2024 | $2.04 | $1.92 | $2.07 | $1.9 | 405,769 | 4,988 | 1.23% |
06-21-2024 | $2.02 | $1.82 | $2.03 | $1.78 | 151,347 | 852 | 0.56% |
06-20-2024 | $1.76 | $2.03 | $2.11 | $1.75 | 533,483 | 9,439 | 1.77% |
06-18-2024 | $1.87 | $1.64 | $1.9276 | $1.63 | 228,539 | 2,484 | 1.09% |
06-17-2024 | $1.88 | $1.9 | $1.9796 | $1.84 | 233,665 | 4,569 | 1.96% |
06-14-2024 | $2.55 | $1.9 | $2.579 | $1.88 | 691,104 | 6,378 | 0.92% |
06-13-2024 | $2.49 | $2.58 | $2.77 | $2.48 | 525,127 | 17,767 | 3.38% |
06-12-2024 | $3.35 | $2.45 | $3.35 | $2.36 | 748,084 | 9,220 | 1.23% |
06-11-2024 | $3.28 | $3.31 | $3.41 | $3.1201 | 648,341 | 15,112 | 2.33% |
06-10-2024 | $2.71 | $3.03 | $3.59 | $2.67 | 967,382 | 24,291 | 2.51% |
06-07-2024 | $2.65 | $2.67 | $2.74 | $2.62 | 182,914 | 2,915 | 1.59% |
06-06-2024 | $2.5 | $2.65 | $2.95 | $2.4 | 1,187,935 | 19,222 | 1.62% |
06-05-2024 | $2.45 | $2.43 | $2.47 | $2.3601 | 188,669 | 842 | 0.45% |
06-04-2024 | $2.39 | $2.42 | $2.45 | $2.32 | 141,663 | 6,707 | 4.73% |
News, Short Squeeze, Breakout and More Instantly...
SHELTON, CT / ACCESSWIRE / July 1, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its current assets and plans towards becoming a successful pharmaceutical company intending to revolutioni...
--News Direct-- NanoViricides CEO Dr Anil Diwan joined Steve Darling from Proactive to share promising news about the company's ultra-broad-spectrum antiviral, NV-387. The antiviral was found to be effective in protecting lungs from damage in a lethally infected Influenza A H3N2 mouse mod...
SHELTON, CT / ACCESSWIRE / June 24, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, comments that the ultra-broad-spectrum antiviral NV-387 could be an important weapon against bird flu H5N1 viruses. Nan...